Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1,600.00% | -95.57% | |||
| Gross Profit | -1,600.00% | 95.57% | |||
| SG&A Expenses | 319.33% | -38.27% | |||
| Depreciation & Amortization | 127.27% | 26.92% | |||
| Other Operating Expenses | 417.14% | -- | |||
| Total Operating Expenses | 644.29% | -70.69% | |||
| Operating Income | -644.29% | 70.69% | |||
| Income Before Tax | -976.15% | 75.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -976.15% | 75.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -976.15% | 75.59% | |||
| EBIT | -644.29% | 70.69% | |||
| EBITDA | -651.50% | 71.00% | |||
| EPS Basic | -77.88% | 75.84% | |||
| Normalized Basic EPS | -77.69% | 75.84% | |||
| EPS Diluted | -77.88% | 75.84% | |||
| Normalized Diluted EPS | -77.69% | 75.84% | |||
| Average Basic Shares Outstanding | 505.42% | 1.01% | |||
| Average Diluted Shares Outstanding | 505.42% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||